The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...

Revenue was largely in line with analyst expectations as Roche turns its attention to a diverse pipeline.

Known as the Kent MS Therapy Centre for 41 years, its name has been changed to the Kent Neuro Therapy Centre. The expanded service will provide therapy for people with MS, Parkinson's disease and ...

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

Selma Blair, 53, gave an inspirational update on ‘TODAY with Jenna & Shenielle’ about her multiple sclerosis as she returns ...

A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Dr. Friese is being honored for his pioneering work discovering how inflammation is associated with nerve cell death in multiple sclerosis.

PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...

Immediately after occupational therapy (OT), people with multiple sclerosis may show small improvements in daily functioning and mental health-related quality of life (HR-QoL), but OT may have little ...